-
Mashup Score: 0Use of cholangioscopy ‘could contribute’ to improved rates of cholangiocarcinoma diagnosis - 21 hour(s) ago
SAN DIEGO — A one-unit increase in cholangioscopy procedures was linked to a 24% increase in subsequent cholangiocarcinoma diagnoses the following year, according to research presented at Digestive Disease Week.These findings highlight the potential role of cholangioscopy in detecting cholangiocarcinoma earlier or more frequently, according to study authors.
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0
SAN DIEGO — Inebilizumab was especially effective for patients with pancreatic and biliary immunoglobulin G4-related disease, with significantly reduced glucocorticoid use for disease control, according to analysis of the MITIGATE trial.Although data from The New England Journal of Medicine published in November 2024 confirmed that inebilizumab (Uplizna, Amgen) significantly reduced the
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
🚨 #DidYouKnow #Inebilizumab showed even greater effectiveness among patients with GI involvement of #IgG4-related disease? "That was something I didn’t count on," Dr. Matthias Lohr told @HealioGastro. 👇 Explore its untapped potential shared at #DDW2025 https://t.co/sHyzNmccfb
-
-
Mashup Score: 0‘More options’ flood IBD market as rival IL-23 drugs face off with Stelara biosimilar boom - 1 day(s) ago
A seismic shift is underway for inflammatory bowel disease therapies as a trio of newly approved interleukin-23 inhibitors are poised to challenge both the resident blockbuster and an avalanche of its biosimilars for market dominance in 2025.“IL-23 inhibition is a novel mechanism of action compared with anti-integrin or anti-[tumor necrosis factor] agents,” Sunanda V. Kane, MD,
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
🗞️ Adults with type 1 #diabetes experiencing recurrent severe hypoglycemia no longer had severe hypoglycemic events after receiving novel islet cell therapy. Learn more about VX-880 and the FORWARD trial 👇 @ATTDconf @PennMedicine #ATTD2025 https://t.co/Z6IKqOrqSm
-
-
Mashup Score: 1Palatable elemental diet a ‘major tool’ for treating bacterial, methanogen overgrowth - 1 day(s) ago
A 2-week course of a palatable elemental diet appeared well-tolerated and significantly modulated the gut microbiome in patients with small intestinal bacterial overgrowth and intestinal methanogen overgrowth, according to study results.Notably, 83% of participants reported symptom improvement, some of which was sustained or even improved further after reintroduction of a regular diet.
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
📊 A clinical trial led by @AliRezaieMD and team @CedarsSinai found that a palatable elemental diet relieved symptoms in 83% of patients with SIBO or IMO. A promising non-pharmacologic approach to managing these challenging GI disorders. #SIBO #IBS https://t.co/yxfP2SZBAn
-
-
Mashup Score: 1
SAN DIEGO — An AI-driven, 3D spatial multimodal analysis exposed substantial immune and structural dysregulation of the duodenum in patients with type 2 diabetes, according to research presented at Digestive Disease Week.This concept of “diabetic duodenopathy” — and the insights gained from this analysis — could lead to new strategies for targeted and novel treatment
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
❗ 👀 News from #DDW25! Researchers at @CedarsSinai, led by @babudayyeh, found duodenal changes that show up before Type 2 diabetes is diagnosed. Could your gut be warning you before your blood sugar does? #T2D #GutHealth https://t.co/RWGsqHbZ4U
-
-
Mashup Score: 0‘Preserving the liver’: ProCure On-Demand, OrganOx team up to expand transplant access - 2 day(s) ago
A new partnership between OrganOx Ltd. and ProCure On-Demand seeks to improve the efficiency and quality of liver recovery and availability for transplantation, according to a press release.The collaboration combines the OrganOx metra normothermic machine perfusion (NMP) platform with ProCure’s surgical, perfusion, preservation and logistics services. The NMP technology, which has been used
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
A new partnership between @organ_ox and @ProCureODX_USA will make liver transplants more accessible to patients across the country. 🩺😊 The collaboration will make @organ_ox’s normothermic machine perfusion platform available nationwide. #LiverTransplant https://t.co/HeiHvtcYLk
-
-
Mashup Score: 7
The metabolites in fermented cabbage protected polarized intestinal epithelial cells against damage by proinflammatory cytokines, according to a study published in Applied and Environmental Microbiology.These beneficial effects were not observed with raw cabbage, findings showed.
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
A study conducted at @ucdavis and published in @AppEnvMicro found that metabolites in #sauerkraut may protect the intestinal barrier against damage by proinflammatory cytokines. https://t.co/SpoztrKVGo
-
-
Mashup Score: 57‘More options’ flood IBD market as rival IL-23 drugs face off with Stelara biosimilar boom - 3 day(s) ago
A seismic shift is underway for inflammatory bowel disease therapies as a trio of newly approved interleukin-23 inhibitors are poised to challenge both the resident blockbuster and an avalanche of its biosimilars for market dominance in 2025.“IL-23 inhibition is a novel mechanism of action compared with anti-integrin or anti-[tumor necrosis factor] agents,” Sunanda V. Kane, MD,
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
🗞️ Adults with type 1 #diabetes experiencing recurrent severe hypoglycemia no longer had severe hypoglycemic events after receiving novel islet cell therapy. Learn more about VX-880 and the FORWARD trial 👇 @ATTDconf @PennMedicine #ATTD2025 https://t.co/Z6IKqOrqSm
-
-
Mashup Score: 13Palatable elemental diet a ‘major tool’ for treating bacterial, methanogen overgrowth - 4 day(s) ago
A 2-week course of a palatable elemental diet appeared well-tolerated and significantly modulated the gut microbiome in patients with small intestinal bacterial overgrowth and intestinal methanogen overgrowth, according to study results.Notably, 83% of participants reported symptom improvement, some of which was sustained or even improved further after reintroduction of a regular diet.
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
📊 A clinical trial led by @AliRezaieMD and team @CedarsSinai found that a palatable elemental diet relieved symptoms in 83% of patients with SIBO or IMO. A promising non-pharmacologic approach to managing these challenging GI disorders. #SIBO #IBS https://t.co/yxfP2SZBAn
-
-
Mashup Score: 0
SAN DIEGO — Inebilizumab was especially effective for patients with pancreatic and biliary immunoglobulin G4-related disease, with significantly reduced glucocorticoid use for disease control, according to analysis of the MITIGATE trial.Although data from The New England Journal of Medicine published in November 2024 confirmed that inebilizumab (Uplizna, Amgen) significantly reduced the
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
🚨 #DidYouKnow #Inebilizumab showed even greater effectiveness among patients with GI involvement of #IgG4-related disease? "That was something I didn’t count on," Dr. Matthias Lohr told @HealioGastro. 👇 Explore its untapped potential shared at #DDW2025 https://t.co/sHyzNmccfb
-
⚕️ The use of #cholangioscopy was linked to increased diagnosis of #cholangiocarcinoma, a “relatively rare” cancer of the bile ducts, according to research from @EricaParkMD and colleagues @OSUWexMed and presented @DDWMeeting. 🩺 #DDW25 https://t.co/cmUCPiv6TX